Skip to content

APOLIERCONSULT

Absorbed by MULTIPHARMA on 12-06-2025 KBO/BCE: BE 0840.244.484

Purpose, financial year and meetings according to the articles of association

Name, seat, purpose and duration

PurposeThe purpose describes the activities the company may carry out under its articles.
“Aan haar aandeelhouders een rechtstreeks of onrechtstreeks vermogensvoordeel uit te keren of te bezorgen”
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited

General meeting and financial year

Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Second Thursday of June at 18:00

Articles of association, deed of 09-11-2023 (in Dutch)

Inactive

Absorbed by MULTIPHARMA in April 2025

APOLIERCONSULT is no longer in the KBO register. MULTIPHARMA took it over in a merger by absorption, published in the Belgian Official Gazette on 24 June 2025.

Status
Inactive
Reason
Merger by absorptionBelgian Official Gazette, 24 June 2025 · deed
Absorbed by
MULTIPHARMA · 0866.855.346
Last annual accounts
financial year to 31 December 2024
Last registered office
Square Marie Curie 30, 1070 Anderlechtas published on 24 June 2025
Legal form
Private limited company
First annual accounts
financial year 2012
Official KBO record

Documents and sources